Articles Tagged With: resistance
-
Baloxavir Marboxil (Xofluza)
Baloxavir marboxil is a novel, oral, antiviral agent approved by the Food and Drug Administration (FDA) on Oct. 24, 2018, for the treatment of acute uncomplicated influenza in patients 12 years of age and older.
-
Infectious Disease Alert Updates
Metagenomics for Prosthetic Joint Infection; Helicobacter pylori: A Mini Primer
-
Factors Associated With Urinary Tract Infections Caused by Multidrug-resistant Gram-negative Bacteria
A multicenter, retrospective, cohort study from southern and eastern Europe identified predictive factors for multidrug-resistant complicated urinary tract infections (cUTI), which included male sex, cUTI acquisition in a healthcare facility, presence of a Foley catheter, having a UTI in the previous year, and receiving an antibiotic in the preceding 30 days.
-
In Patients Who Self-catheterize, Antibiotic Prophylaxis Prevents UTIs but Increases Antibiotic Resistance
A randomized, open-label, superiority trial found that daily antibiotic prophylaxis for patients who use clean, intermittent self-catheterization reduced symptomatic urinary tract infections by 48% over a 12-month period. Antibiotic resistance became prevalent in urinary isolates from the group receiving prophylaxis compared to controls.
-
Radar Is Up for Rise of Mycoplasma Genitalium
Concerns about Mycoplasma genitalium, a sexually transmitted infection, are on the rise.
-
Push Is on to Combat Drug-resistant Gonorrhea
In a recently released study, Centers for Disease Control and Prevention (CDC) researchers report that while 81% of patients diagnosed with gonorrhea were treated using dual therapy, nearly one in five were treated with a different regimen.
-
Infectious Disease Alert Updates
House Mice as Vectors; Eat Your Fruits and Vegetables — or You Might Get TB!
-
Dealing With Multidrug-resistant Organisms on a National Level: CDC Successes and Problems on the Horizon
CDC efforts, implemented at the local level, have been associated with a modest reduction in the incidences of Escherichia coli and Klebsiella pneumoniae with an ESBL phenotype and a more dramatic reduction in carbapenem-resistant Enterobacteriaceae.
-
Emerging Infectious Disease and Emergency Medicine
There are many emerging infections for which the emergency physician must remain clinically vigilant. Although many infections may not represent true emergencies, it is important for ED providers to understand the epidemiology, presentation, and treatment of some of today’s common and life-threatening infections.
-
Research Identifies Potential New Gonorrhea Treatments
About 820,000 new gonococcal infections occur in the United States each year, with some 570,000 appearing in young people ages 15-24. In an effort to stem the tide of infection, science has identified a potential new treatment, which uses a peptide to disrupt an enzyme the microbe needs to respirate.